PATIENT ENGAGEMENT

Patient Organization

The patient comes first

For Bayer, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.

 

Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.

 

Bayer cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.

 

Our principles

Cooperation between Bayer and patient organizations is based on the following principles.

  1. In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:
    • raising awareness for certain diseases by improving diagnostic possibilities and preventive measures, knowing the patients' prospects and needs,
    • understanding diseases and making sure that patients receive the best medical treatment available,
    • improving the information provided to the patients,
    • supporting medical innovations.
  2. Bayer and the patient organizations comply with international and national laws and regulations.
  3. Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.
  4. Bayer respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.

 

Overview of cooperation with patient organizations in Europe in 2019

The following is a list of patient organizations with which Bayer and its affiliated companies in Europe cooperated in 2019.

 

Headquarters:

Bayer Company

Bayer AG

Contract date

21.04.2020

Amount

150.000 EUR

Purpose of interaction

Sponsorship of annual patient representative meeting 

 

Bayer Company

Bayer AG

Contract date

27.04.2020

Amount

50.000 EUR

Purpose of interaction

Sponsorship of World Scleroderma Day

 

Bayer Company

Bayer AG

Contract date

29.06.2020

Amount

110.000 EUR

Purpose of interaction

Support "Stroke Support Organisation Faculty Tool" (SSOFT)  maintenance and marketing and European Stroke Forum (focusing on treatment, management and care and support of stroke survivors after initial discharge from the hospital)

 

Bayer Company

Bayer AG

Contract date

30.06.2020

Amount

100 EUR

Purpose of interaction

Patient feedback session for a project

 

Bayer Company

Bayer AG

Contract date

2020

Amount

5.000 EUR

Purpose of interaction

Förderkreis-Mitgliedschaft 2020 im Kindernetzwerk e.V.

 

Bayer Company

BCC AG

Contract date

04.09.2020

Amount

30.000 EUR

Purpose of interaction

Annual Sponsorship of the International Diabetes Federation to support the organizations to fulfill its mission of being the global voice of people living with diabetes, promoting diabetes care, prevention and a cure worldwide.

 

Bayer Company

BCC AG

Contract date

10.02.2020

Amount

400 CAD

Purpose of interaction

Virtual Meeting EURETINA (Honoraria nAMD)

 

Bayer Company

BCC AG

Contract date

10.02.2020

Amount

400 CAD

Purpose of interaction

Virtual Meeting EURETINA (Honoraria Vision Academy)

 

Bayer Company

BCC AG

Contract date

04.07.2020

Amount

11.600 CAD

Purpose of interaction

nAMD Barometer Virtual Meeting Honoraria

 

Bayer Company

BCC AG

Contract date

29.05.2020

Amount

800 CAD

Purpose of interaction

Vision Academy SC Meeting Honoraria

 

Bayer Company

BCC AG

Contract date

29.08.2020

Amount

800 CAD

Purpose of interaction

Vision Academy Annual Meeting Honoraria

 

Bayer Company

BCC AG

Contract date

25.10.2020

Amount

800 CAD

Purpose of interaction

Vision Academy SC Meeting Honoraria

 

Bayer Company

BCC AG

Contract date

11.10.2020

Amount

4.000 CAD

Purpose of interaction

nAMD Barometer LC Activities 2020

 

Bayer Company

BCC AG

Contract date

01.09.2020

Amount

50.000 USD

Purpose of interaction

Annual sponsorship of the International Agency for Prevention of Blindness an to undertake work in advocating for the implementation of the Universal Eye Health and the Global Action Plan, support the development, roll out and uptake of the WHO’s ‘World Report on Vision’, continued engagement of the Sustainable Development Goals and provision of membership services.

 

Bayer Company

BCC AG

Contract date

2020

Amount

52.500 EUR

Purpose of interaction

EHC annual membership fees and congress sponsorship 2020

 

Bayer Company

BCC AG

Contract date

18.12.2020

Amount

500 EUR

Purpose of interaction

EU Patient Council 2020 / honorarium

 

Bayer Company

BCC AG

Contract date

18.12.2020

Amount

374 EUR

Purpose of interaction

EU Patient Council 2020 / honorarium

 

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

1.579,64 CHF

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

1.795,7 CHF

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

381,73 CHF

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

1.175,2 CHF

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

643,9 CHF

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

952,9 CHF

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

1.203,55 CHF

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

4.894,09 EUR

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

5.099,39 EUR

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

1.768,23 EUR

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

3.536,46 EUR

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

1.665,58 EUR

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

3.331,16 EUR

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

2.000 EUR

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

Bayer Company

BCC AG

Contract date

19-21.01.2020

Amount

1.562,93 EUR

Purpose of interaction

Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

Europe:

Reports can be received from

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

Bayer AB- Bayer Scandinavia
Iina Wargh
Gustav III:s Boulevard 56
169 26 Solna

Reports can be received from    

SC Bayer SRL 
Bayer Pharmaceuticals Division 
Sos. Pipera nr. 42., Sector 2 
NUSCO Tower fl. 1,16,17 
020112, Bucharest
Romania

Reports can be received from    

Bayer Pharma d.o.o. 
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade

Reports can be received from    

Bayer d.o.o. 
Lucija Zlodi Gosnik
Bravnicarjeva 13
1000 Ljubljana